Mong-Hong Lee is currently a Professor in the Department of Molecular and Cellular Oncology of University of Texas MD Anderson Cancer Center, Houston, Tex, USA, and a Faculty Member at The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS), Austin, Tex, USA. Dr. Lee received his Ph.D. degree in molecular, cellular, and developmental biology from the University of Pittsburgh, Pittsburgh, Pa, USA, where he received the Stanton C. Crawford Award for teaching excellence. He then went on to complete a postdoctoral fellowship while serving as a Research Associate at Howard Hughes Medical Institute, Chevy Chase, Md, USA, and Memorial Sloan-Kettering Cancer Center, New York, NY, USA. After completing his fellowship, Dr. Lee came to M. D. Anderson in as an Assistant Professor (tenure track). He was promoted to Professor (tenured) in 2010. Dr. Lee’s research in cancer area includes characterizing the roles of Cdk inhibitors (CKIs) in cancer formation and exploiting signaling regulation in cancer therapy. He has set up research projects focusing on (1) roles of two CKI molecules that he was involved in cloning (p27, 14-3-3 s) in tumorigenesis, (2) COP9 signalosome signaling regulation, (3) investigating the impact of hypoxia and Pim1 kinase in drug resistance, (4) employing Aurora B kinase inhibitor for cancer therapym, (5) p53-MDM2 signaling regulation and DNA damage, (6) Myc ubiquitination regulation, and (7) glycolysis and cancer metabolism. During his time at M. D. Anderson, Dr. Lee has been the principal investigator or a coprincipal investigator for nine funded research projects. He also has been a grant reviewer for several funding agencies. Dr. Lee has been honored for his research/education activities, led by the Susan G. Komen Breast Cancer Foundation Research Award (2001), Fleming and Davenport Research Award (2001),William G. McGowan Foundation Research Award (1998), and John P. Mcgovern outstanding teacher award (2009).
Biography Updated on 27 January 2011